Defining and Characterizing the Progression of Type 2 Diabetes

被引：262
作者：
Fonseca, Vivian A. [1 ]
机构：
[1] Tulane Univ, Med Ctr, New Orleans, LA 70118 USA
来源：
DIABETES CARE | 2009年 / 32卷
关键词：
BETA-CELL FUNCTION; BLOOD-GLUCOSE CONTROL; INSULIN-RESISTANCE; TOLERANCE; DISEASE; COMPLICATIONS; THERAPY; FAILURE; INTOLERANCE; PREDICTORS;
D O I：
10.2337/dc09-S301
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S151 / S156
页数：6
相关论文
共 37 条
  • [11] Mode of onset of type 2 diabetes from normal or impaired glucose tolerance
    Ferrannini, E
    Nannipieri, M
    Williams, K
    Gonzales, C
    Haffner, SM
    Stern, MP
    [J]. DIABETES, 2004, 53 (01) : 160 - 165
  • [12] The natural course of β-cell function in nondiabetic and diabetic individuals -: The insulin resistance atherosclerosis study
    Festa, A
    Williams, K
    D'Agostino, R
    Wagenknecht, LE
    Haffner, SM
    [J]. DIABETES, 2006, 55 (04) : 1114 - 1120
  • [13] SIZE OF PANCREAS IN DIABETES-MELLITUS - A STUDY BASED ON ULTRASOUND
    FONSECA, V
    BERGER, LA
    BECKETT, AG
    DANDONA, P
    [J]. BRITISH MEDICAL JOURNAL, 1985, 291 (6504) : 1240 - 1241
  • [14] β-cell genes and diabetes -: Molecular and clinical characterization of mutations in transcription factors
    Frayling, TM
    Evans, JC
    Bulman, MP
    Pearson, E
    Allen, L
    Owen, K
    Bingham, C
    Hannemann, M
    Shepherd, M
    Ellard, S
    Hattersley, AT
    [J]. DIABETES, 2001, 50 : S94 - S100
  • [15] Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)
    Gerstein, Hertzei C.
    [J]. AMERICAN HEART JOURNAL, 2008, 155 (01) : 26 - 32
  • [16] Pancreatic volume in type 1 and type 2 diabetes mellitus
    Goda, K
    Sasaki, E
    Nagata, K
    Fukai, M
    Ohsawa, N
    Hahafusa, T
    [J]. ACTA DIABETOLOGICA, 2001, 38 (03) : 145 - 149
  • [17] Islet amyloid: A critical entity in the pathogenesis of type 2 diabetes
    Hull, RL
    Westermark, GT
    Westermark, P
    Kahn, SE
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (08) : 3629 - 3643
  • [18] Islet amyloid: A long-recognized but underappreciated pathological feature of type 2 diabetes
    Kahn, SE
    Andrikopoulos, S
    Verchere, CB
    [J]. DIABETES, 1999, 48 (02) : 241 - 253
  • [19] Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
    Kahn, Steven E.
    Haffner, Steven M.
    Heise, Mark A.
    Herman, William H.
    Holman, Rury R.
    Jones, Nigel P.
    Kravitz, Barbara G.
    Lachin, John M.
    O'Neill, M. Colleen
    Zinman, Bernard
    Viberti, Giancarlo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (23) : 2427 - 2443
  • [20] Risk of glucose intolerance and diabetes in hemipancreatectomized donors selected for normal preoperative glucose metabolism
    Kumar, Anjali F.
    Gruessner, Rainer W. G.
    Seaquist, Elizabeth R.
    [J]. DIABETES CARE, 2008, 31 (08) : 1639 - 1643
1234